GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Inari Medical Inc (NAS:NARI) » Definitions » Price-to-Tangible-Book

NARI (Inari Medical) Price-to-Tangible-Book : 41.86 (As of Dec. 14, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Inari Medical Price-to-Tangible-Book?

As of today (2024-12-14), Inari Medical's share price is $55.59. Inari Medical's Tangible Book per Share of Sep. 2024 for the quarter that ended in Sep. 2024 was $1.33. Hence, Inari Medical's Price to Tangible Book Ratio of today is 41.86.

The historical rank and industry rank for Inari Medical's Price-to-Tangible-Book or its related term are showing as below:

NARI' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 7.64   Med: 17.45   Max: 42.43
Current: 41.8

During the past 6 years, Inari Medical's highest Price to Tangible Book Ratio was 42.43. The lowest was 7.64. And the median was 17.45.

NARI's Price-to-Tangible-Book is ranked worse than
98.71% of 698 companies
in the Medical Devices & Instruments industry
Industry Median: 2.86 vs NARI: 41.80

A closely related ratio is called PB Ratio. As of today, Inari Medical's share price is $55.59. Inari Medical's Book Value per Sharefor the quarter that ended in Sep. 2024 was $7.44. Hence, Inari Medical's P/B Ratio of today is 7.47.


Inari Medical Price-to-Tangible-Book Historical Data

The historical data trend for Inari Medical's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inari Medical Price-to-Tangible-Book Chart

Inari Medical Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
Get a 7-Day Free Trial - 21.47 19.20 8.23 37.61

Inari Medical Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.32 37.61 30.31 36.70 31.05

Competitive Comparison of Inari Medical's Price-to-Tangible-Book

For the Medical Devices subindustry, Inari Medical's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Inari Medical's Price-to-Tangible-Book Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Inari Medical's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Inari Medical's Price-to-Tangible-Book falls into.



Inari Medical Price-to-Tangible-Book Calculation

Inari Medical's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Sep. 2024 )
=55.59/1.328
=41.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Inari Medical Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Inari Medical's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Inari Medical Business Description

Traded in Other Exchanges
Address
6001 Oak Canyon, Suite 100, Irvine, CA, USA, 92618
Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous Disease. Its product portfolio includes; ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTriever System product is used for the treatment of pulmonary embolism, InThrill system to treat small vessel thrombosis, LimFlow system and others. Geographically, the company generates majority of its revenue from United States and rest from International markets.
Executives
Andrew Hykes officer: Chief Operating Officer C/O INARI MEDICAL, INC., 9 PARKER AVENUE, SUITE 100, IRVINE CA 92618
William Hoffman director, officer: President and CEO C/O INARI MEDICAL, INC., 9 PARKER, SUITE 100, IRVINE CA 92618
Mitch C. Hill, officer: Chief Financial Officer 1009 TENNYSON DRIVE, SOUTHLAKE TX 76902
Thomas Tu officer: Chief Medical Officer C/O INARI MEDICAL, INC., 9 PARKER AVENUE, SUITE 100, IRVINE CA 92618
Rebecca Chambers director 3052 ORCHARD DR., SAN JOSE CA 95134
Donald B Milder director ONE SANSOME STREET, SUITE 1650, SAN FRANCISCO CA 94104
Robert Keith Warner director C/O RXSIGHT, INC., 100 COLUMBIA, ALISO VIEJO CA 92656
Catherine M. Szyman director C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE CA 92614
Cynthia L Lucchese director 7966 N. ILLINOIS STREET, INDIANAPOLIS IN 46260
Mead Dana G Jr. director 2750 SAND HILL ROAD, MENLO PARK CA 94025
Jonathan D Root director 2735 SAND HILL ROAD, MENLO PARK CA 94025
Cooperatieve Gilde Healthcare Iv U.a. 10 percent owner NEWTONLANN 51, UTRECHT P7 3508AB
Kirk G. Nielsen director, 10 percent owner ONE SANSOME STREET, SUITE 3630, SAN FRANCISCO CA 94104
Gilde Healthcare Iv Management B.v. 10 percent owner NEWTONLAAN 91, UTRECHT P7 3584 BP
Gilde Healthcare Holding B.v. 10 percent owner NEWTONLAAN 91, PO BOX 85067, 3508 UTRECHT P7 AB